Bengaluru, India · Founded 2020 · Privately Held (backing)
Developer of an AI-powered platform for antibody discovery intended to accelerate the development of novel antibody therapeutics. ImmunitoAI is based in Bengaluru, India and was founded in 2020. Its last reported valuation was $21.4 million in Nov 2025. It has raised $9.1 million.
Last reported valuation
$21.4M
Oct 2026
Priced at
—
Total raised
$9.1M
Last round
—
Team — not yet on record
No current team members for ImmunitoAI are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ImmunitoAI with a free account
·The complete investor list: 20 names
·Watch ImmunitoAI: the Monday email on marks, rounds and moves
